WeVote
Log In

Bill

Bill

A 6160

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

2024-2025 Regular Session Introduced by Clinton Calabrese

Creates commission to develop comprehensive Alzheimer's disease strategy plan for New Jersey addressing patient care, family support, and policy recommendations.

#commissions #disease
0
WeVote Research Nonpartisan
Bill Summary · A 6160

Legislative bill overview

Bill A 6160 establishes a commission tasked with studying and developing a comprehensive master plan to address Alzheimer's disease in New Jersey. The commission would examine the state's current capacity to treat, support, and care for Alzheimer's patients and their families, and make recommendations for policy improvements.

Why is this important

Alzheimer's disease affects over 120,000 New Jersey residents, creating significant burdens on healthcare systems, families, and caregivers. A coordinated state master plan could identify gaps in services, improve care coordination, and reduce costs by addressing the disease systematically rather than through fragmented programs.

Potential points of contention

  • Cost and timeline: The bill does not specify commission funding, staffing size, or when the plan must be completed, leaving unclear implementation costs and feasibility
  • Authority and enforcement: The bill establishes study requirements but does not clarify whether recommendations would be binding or how the state would enforce or fund proposed changes
  • Scope limitations: The plan may duplicate existing efforts from federal agencies, the Alzheimer's Association, and healthcare providers already working on this issue in New Jersey

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.